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Summary 
Interleukin 7 (IL-7) stimulates the proliferation of B cell progenitors, thymocytes, and mature 
T cells through an interaction with a high affinity receptor (IL-7R) belonging to the hematopoietin 
receptor superfamily. We have further addressed the role of IL-7 and its receptor during B and 
T  cell development by generating mice genetically deficient in IL-7R.  Mutant mice display a 
profound reduction in thymic and peripheral lymphoid cellularity. Analyses of lymphoid progenitor 
populations in IL-7R-deficient mice define precisely those developmental stages affected by the 
mutation and reveal a critical role for IL-7R during early lymphoid development. Significantly, 
these studies indicate that the phase of thymocyte expansion occurring before the onset of T 
cell receptor gene rearrangement is critically dependent upon, and mediated by the high affinity 
receptor for IL-7. 
T 
he development of lymphoid cells from muhipotential 
progenitors is dependent upon growth,  survival,  and 
differentiation factors produced by various stromal cells. Long- 
term cultures supporting the growth of murine B lineage 
cells from uncommitted precursors can be established from 
adult bone marrow and have been instrumental in defining 
factors that  influence B  cell development (1,  2).  IL-7 was 
identified and cloned based upon its ability to induce short- 
term proliferation of B  cell progenitors in the absence of 
stromal cells (3). The requirement for IL-7 in the prolifera- 
tion of B cell precursors has been clearly established in that 
stromal cell variants that no longer express IL-7 are incapable 
of efficiently supporting B ceU progenitor growth, and neu- 
tralizing antibodies to IL-7 or IL-7R severely inhibit B cell 
development in vitro and in vivo (4-6). 
Evidence suggests that the IL-7-responsive B lineage popu- 
lation displays an early/late pro-B cell phenotype character- 
ized by the expression of B220,  heat stable antigen (HSA), 
and leukosialin (CD43), the presence of D-J and V-D-J rear- 
rangements and the absence of surface IgM (7). Less mature 
B lineage cells do not proliferate or differentiate in response 
to IL-7 in vitro, although they do express IL-7R (8). IL-7R 
expression is lost after productive light chain rearrangement 
in pre-B ceils, and thus subsequent stages of B cell matura- 
tion are likely to be directly IL-7 independent (9). 
The role of IL-7 in T cell development is less well defined. 
IL-7 is expressed in the thymus and has been shown to stimu- 
late the growth of immature CD4-/CD8-  adult and fetal 
thymocytes (10,  11) and promote rearrangement of T  cell 
receptor 3 and 3, chains in fetal thymus and fetal liver culture 
systems (12, 13). Additionally, treatment of mice with neu- 
tralizing  antibodies  to  IL-7  or  IL-7R  results  in  thymic 
hypoplasia (5,  6),  and overexpression of IL-7 in transgenic 
mice perturbs thymocyte cellularity (14). However, it is not 
known to what extent T cell development within the thymus 
is IL-7 dependent and which of the thymic subpopulations 
have specific requirements for IL-7-induced proliferation and 
survival in vivo. 
We have taken a genetic approach to further elucidate the 
role of IL-7 and its high affinity receptor in the proliferation 
and maturation of B and T lineage cells in vivo by analyzing 
lymphoid development in mice lacking the high affinity IL- 
7R.  Results obtained from these analyses implicate IL-7R 
as a critical signaling molecule in the proliferation of early 
B cell progenitors undergoing heavy chain rearrangements 
and in early thymocyte expansion prior to the acquisition 
of rearranged T  cell receptor genes. 
Materials and Methods 
Gene Targeting.  An IL-7R gene targeting construct was pre- 
pared by inserting a 1-kb MCneo cassette (15) into a HindlII site 
within the third exon of the IL-7R gene, occurring at approxi- 
mately amino acid 90 of the 180 amino acid extracellular domain 
(16). A thymidine kinase cassette (MC-TK) was inserted into the 
3' end of the vector (15). AB1 embryonic stem (ES) cells were main- 
tained, electroporated, and selected in the presence of G418 and 
gandclovir as described  previously (17). Approximately 1/250 G418 
plus ganciclovir resistant colonies carried an IL-7R allele altered 
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Southern blot  analyses. 
Mice.  C57B1/6  were obtained from Charles River Laborato- 
ries (Wilmington,  MA),  129/J were obtained from The Jackson 
Laboratory (Bar Harbor, ME), and Swiss  Webster were obtained 
from Taconic Farms, Inc. (Germantown, NY). All mice were main- 
tained under  specific pathogen-free conditions.  ES cells carrying 
the  mutant  IL-7R  allele  were  injected  into  day  3.5  C57B1/6 
blastocysts and transferred to day 2.5 pseudopregnant Swiss Web- 
ster recipients.  Resulting male chimeras were bred to 129/J females 
and offspring analyzed for germline transmission of the altered al- 
lele by PCR analysis of ear biopsy DNA.  Mice homozygous for 
the IL-7R mutation (IL-7R-/-) were generated either from in- 
tercrosses between heterozygotes (IL-7R+/-) or from IL-7R-/- 
breeding pairs. When necessary, genotypes were determined by PCK 
analysis of ear biopsy DNA. Throughout these studies  either age- 
matched or littermate IL-7R+/-  and IL-7K+/+  mice were used 
as controls. 
Molecular and Biochemical  Analyses.  Reverse transcriptase PCR 
reactions were performed on poly(A) +  RNA according to manufac- 
turer's specifications  (Pharmacia LKB, Piscataway,  NJ). Scatchard 
analyses were performed on primary cell suspensions using iodi- 
hated murine IL-7 as described (18). Bone marrow-derived macro- 
phages were isolated and cultured in the presence of colony stimu- 
lation  factor 1 as described  (19). 
Immunofluorescent  Staining and Flow Cytometry.  Four-color anal- 
ysis of bone marrow was performed using reagents and protocols 
described previously (6, 7). Analyses of thymic and peripheral lym- 
phoid populations  were performed as described (20). 
Results  and Discussion 
Generation and Gross Characterization of  lL-7R-deficient (IL- 
7R-/-)  Mice.  Mice lacking a functional IL-7R gene were 
created by inserting  a neo cassette in the third  exon of one 
IL-7R allele by homologous  recombination  of a  gene  tar- 
geting vector in 129Sv-derived ES cells (Fig.  1 A). The mu- 
tant  allele encodes  less than  half of the IL-7R  extracellular 
domain  and  is  thus  expected to represent  a  null  mutation. 
IL-7R-/-  mice were generated from matings between IL- 
7R+/-  mice at the expected Mendelian frequency (data not 
shown) and identified by genomic Southern blot analysis (Fig. 
Figure  1.  Targeted  disruption of the IL-7R locus and molecular char- 
acterization of IL-7K-/- mice. (A) The first six exons encoding the ex- 
tracellular domain of murine IL-7R are depicted, highlighting the initia- 
tion codon (ATG), NH2 terminus (NH2), transmembrane domain (TM), 
and diagnostic BgllI sites. The vector constructed to target the IL-7R gene 
and the probe used to identify  an IL-7R locus altered  by homologous  recom- 
bination are also shown. (B) DNAs isolated from wild-type mice (+/+), 
and mice heterozygous (+/-) or homozygous (-/-) for the mutant IL- 
7R gene were digested with BgllI and subject to Southern blot analysis 
using the indicated probe. The positions of various HindllI X size markers 
are shown. (C) Reverse  transcriptase PCR analysis of splenic cDNA pre- 
pared from adult mice heterozygous (+/-) and homozygous (-/-) for 
the IL-7R mutation using a primer 5' of the MCneo insertion in exon 
3 and a primer derived from exon 4. The PCK products are derived from 
~4,000 splenic cell equivalents and are compared with PCR products ob- 
tained from 200, 2,000, or 20,000 molecules of control IL-7R. cDNA. 
Reagent only (0) and genomic DNA controls are included and the posi- 
tions of various HindlII X size markers are shown. 
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and IL-TR -/-  Cells 
Control  IL-7R- / - 
Source  Site number  K,  Site number  K, 
M-1  M-1 
Thymus  166  1.6  x  101~  ND*  ND 
Spleen  420  7.0  x  109  ND  ND 
BM*  160  4.3  x  109  ND  ND 
BMMS  30  3.2  x  10  t~  ND  ND 
Cells were prepared as described  (19, 20) and examined for high affmity 
binding to radiolabeled murine IL-7 (18). Site numbers and K, values 
were determined  by Scatchard  analyses of complete  sets of binding data. 
* Not detectable. Site numbers  <"10 molecules/cell  are below the limit 
of accurate detection and are considered not detectable. 
Bone marrow. 
S  Bone marrow-derived  macrophages (19). 
1 B). Reverse transcriptase PCIK analysis using primers that 
flank the neo insertion in exon 3 confirmed the lack of wild- 
type IL-7R message in IL-7R-/-  splenocytes, although ex- 
pression of the expected mutant IL-7R-MCneo hybrid tran- 
script was readily apparent (Fig.  1 C). 
Several lines of evidence indicate that IL-7R-/-  hemato- 
poietic cells fail to bind IL-7 with high affinity and do not 
respond to IL-7. As shown in Table 1, Scatchard analyses from 
control marrow, spleen, and thymus cell suspensions as well 
as from cultured bone marrow-derived macrophages revealed 
site numbers and binding affinities  comparable to those de- 
scribed previously (18), whereas high affinity IL-7 binding 
to IL-7R-/-  cells was undetectable. These data indicate that 
the cloned IL-7R is the only molecule on murine hemato- 
poietic cells capable of binding IL-7 with high affinity and 
that the introduced IL-7Ik mutation is in fact a null muta- 
tion. Additionally, B cell progenitor proliferation was readily 
apparent in IL-7 supplemented newborn liver cultures estab- 
lished from IL-7R+/- mice but not in cultures derived from 
IL-7R-/-  littermates (data not shown).  In contrast, par- 
allel cultures supplemented with steel factor supported my- 
eloid development indistinguishable from that of control cul- 
tures (data not shown). 
Gross pathological analyses  of IL-7R-/-  mice did not 
reveal any nonlymphoid anomalies and both sexes were fer- 
tile.  However, newborn and young adult IL-7R-/-  mice 
displayed dramatically reduced thymic and splenic lymphoid 
cellularity relative to either age-matched or littermate con- 
trols (Fig.  2, A  and B). This deficit was observed in both 
B  and T  cell compartments and affected both CD4 §  and 
CD8 + T  cell subsets  (Fig.  2 A). Peripheral and mesenteric 
lymph node cellularities  were also greatly decreased (data not 
shown). Total bone marrow cellularity and CFU-GM potential 
in IL-7R-/-  mice were both comparable to those observed 
in controls, whereas colony formation in response to IL-7 
was observed with control but not IL-7R-/-  bone marrow 
(data not shown). 
Thymocyte Development in IL-7R-/-  Mice Is Blocked at an 
Early Developmental  Stage.  During T cell development, pro- 
thymocytes migrate from the bone marrow into the thymus 
and undergo a phenomenal expansion within the cortex that 
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Figure  2.  Analysis  of  lymphoid  cellularity  in control  and IL-7R-/- mice. (A) Spleens  from 5-12-wk-old  IL-7R-/- mice  (open Mr) and age-matched 
or littermate controls (solid bar) were evaluated for total cellularity  and cellularity  of CD4 +, CD8 § , and IgM + subpopulations. The data represent 
mean and SEM values of 7-12 IL-7R-/-  mice and 5-7 controls. (B) Analysis of thymocyte  cellularity  in control (open circle) and IL-7R-/-  mice 
(solid circle). Thymuses  from 12 IL-7R-/-  mice (5-24 wk of age) and 8 age-matched or littermate controls were evaluated  for total cellularity  and 
cellularity  of the various CD4/CD8 subpopulations. (C) Analysis of the relative  distribution  of thymocyte  subsets in IL-7R-/- (solid  circle) and control 
mice (open circle). Levels  of the CD4/CD8 thymocytes  subsets determined in B are expressed as a fraction of total thymocyte  cellularity. 
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a sequential progression through CD4-/CD8-  and CD4 + / 
CD8 + stages to ultimately yield mature  medullary CD4 + 
or  CD8 +  T  cells  (21).  The  cytokine(s)  required  for  this  lo 3- 
pathway have not been defined, although IL-7 is a reasonable  ~  io2. 
candidate (3, 10-12, 22). IL-7R-/-  mice displayed a marked 
reduction in  thymocyte cellularity.  Whereas  splenic T  cell  lo  1. 
levels in IL-7R.-/-  mice were consistently approximately 
10% those observed in control mice (Fig. 2 A), total thymic  ~o~ 
cellularity among these mice varied between 0.01 and 10% 
of control values (Fig. 2 B). The relative proportions of thymic 
subsets in  IL-7R-/-  mice were similarly variable (Fig.  2 
C).  CD4+/CD8 + thymocytes normally comprise approxi-  ]03 
mately 80% of the thymus (21). This distribution was also  oJ  ~0  2.  db  observed in IL-7R-/-  thymuses where total cellularity was 
at least 1% that of control mice. In marked contrast,  those 
IL-7R-/-  thymuses displaying a total cellularity  significantly 
less  than  this  were composed primarily  of CD4-/CDS- 
cells. The source of this variability is presently not known, 
although it cannot be attributed to differences in age or sex  8 
and is unlikely to be due to strain variation as the IL-7R-/- 
mutation  has been maintained  on a  129 background. 
To determine more precisely what stage of thymocyte de-  ~o  3. 
velopment  is  affected  in  IL-7R-/-  mice,  CD4-/CD8-  co 
o  1o  2-  thymocytes were analyzed for the  expression of HSA and 
CD25 by flow cytometry. The dynamic expression of these  u 
markers defines distinct  stages of CD4-/CD8-  thymocyte  I~ 
development (23). The HSA +/CD25 + fraction present in a  1o  0 
control thymus was dearly underrepresented in an IL-7R-/- 
thymus composed primarily of CD4-/CDS-  cells (Fig.  3, 
A  and B) indicating that T  cell development is affected be- 
fore the surface expression of CD4 and CD8 and before the 
initiation of T cell receptor/3 chain rearrangement.  The ac- 
quisition of CD25 expression by CD4-/CDS-  HSA + cells 
is accompanied by extensive proliferation induced by undefined 
factors provided by the thymic microenvironment  (21). The 
failure of this proliferative transition to occur in IL-7R-/- 
mice suggests an obligatory requirement for IL-7 and its high 
affinity  receptor  for  efficient  expansion  of CD4-/CD8- 
thymocytes and implicates IL-7R as a key signaling molecule 
driving the first major phase of early thymocyte expansion. 
Mutations  affecting/~ chain rearrangement  or signal trans- 
duction through this chain arrest the second major phase of 
thymocyte expansion (24, 25), which ultimately yields post- 
mitotic  cortical  CD4+/CD8 §  thymocytes.  That  the  IL- 
7R-/-  mutation manifests itself prior to this phase precludes 
a direct  evaluation of the role of IL-7R in this  process. 
B Cell Development in IL-7R-/-  Mice Is Affected at the Pro- 
B  Cell Stage.  To more closely examine the stage at which 
development of conventional B cells is affected in IL-7R-/- 
mice,  the  B220 +  IgM-  B  cell precursor population  from 
adult bone marrow was further separated on the basis of CD43 
and HSA expression (7). As shown in Fig. 4, the predomi- 
nant CD43 +  HSA bright and CD43-  HSAbrig  ht fractions  present 
in gated B220 +  IgM- control marrow were undetectable in 
IL-7R-/-  marrow. These fractions correspond to, respec- 
tively, the IL-7 responsive early/late pro-B population and the 
IL-7 nonresponsive pre B population.  The CD43 + HSA  auH 
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Figure  3.  Immunofluorescent 
profiles of CD4-/CD8- thymo- 
cytes in control and IL-TR-/- 
mice. Gated CD4-/CDS-  thy- 
mocytes from a young adult IL- 
7R-/-  mouse (A) and an age- 
matched control (B) were  analyzed 
for the expression of HSA and 
CD25 by flow cytometry. The 
axis  divisions refer  to  log10 
fluorescence units. The data are 
representative histograms of mu- 
tant thymuses  composed  predom- 
inantly of CD4 -/CDS- cells. 
fraction representing pre-pro-B cells was not diminished in 
IL-7R-/-  mice, suggesting that B cell development up to 
and including this stage is unaffected by the mutation  and 
that survival of these populations does not depend upon high 
affinity IL-7R. It is interesting to note that a population of 
CD43 + cells expressing very low levels of HSA was easily 
detected in IL-7R-/-  marrow but undetectable in control 
marrow. This fraction may represent yet another discernible 
fraction of B cell precursors that lies intermediate between 
uncommitted progenitors and pre-pro-B cells whose presence 
is unmasked in IL-7R-/-  marrow simply due to inefficient 
proliferation  of subsequent developmental stages. 
The results described in this report argue that efficient lym- 
phoid development in mice is critically dependent upon IL- 
7R. However, the observation that mature B and T cells were 
present in the periphery of IL-7R.-/-  mice indicates that 
to a limited extent,  lymphoid development can proceed in 
1958  Lymphoid  Development in IL-7R-deficient Mice A 
10  4 
10  3 
a  102 
O 
101 
10(i00  ~  ,  ,  101  102  103 
Heat Stable Antigen 
104 
103 
0~  ~  10  ~  102  10  J~ 
1 
Heat Stable Antigen 
10  4 
I 0  4 
Figure 4.  Immunofluorescent 
profiles of B cell progenitor  sub- 
populations in the bone marrow. 
Gated B220+/IgM  -  bone mar- 
row cells from a 5-wk-old IL- 
7R-/-  mouse (A) and an age- 
matched  control  (B) were  analyzed 
for the expression of CD43 and 
HSA by flow  cytometry.  The axis 
divisions refer to log~0 fluores- 
cence units.  The data  are represen- 
tative histograms. 
the absence of an IL-7R-mediated phase of expansion. The 
extent to which impaired expansion during development affects 
the function of these lymphocytes is currently under investi- 
gation. 
Several members of  the hematopoietin receptor family  share 
common receptor subunits (26) and thus receptor mutations 
may yield phenotypes more severe than those observed with 
mutations in their corresponding ligands. For example, mu- 
tations in the IL-2R3/subunit result in human X-linked im- 
munodeficiency  disease (XSCID) (27), whereas lymphoid de- 
velopment is normal in mice lacking IL-2 (28).  Recently it 
has been demonstrated that the IL-2R3' chain is a functional 
component of both the IL-4 and IL-7 receptors (29-31).  Im- 
paired lymphoid development in IL-7R-/-  mice formally 
supports the hypothesis that the severity of XSCID is in part 
due to a compromised IL-7/IL-7R interaction. However, the 
observation that peripheral B cell levels are depressed in IL- 
7K-/-  mice and are apparently unaffected in XSCID pa- 
tients suggests the possibility that IL-7R function in B cell 
progenitors may not be strictly dependent on IL-2R% 
Although IL-7R-/-  mice display a qualitatively similar 
phenotype to mice treated with neutralizing antibodies to 
IL-7, the propensity for hematopoietin receptors to use shared 
subunits raises the possibility that the IL-7R mutation has 
impinged upon additional receptor systems. We have recently 
cloned a cDNA encoding a novel stromal cell-derived cytokine, 
thymic stromal-derived lymphopoietin (TSLP), whose activi- 
ties on a variety of lymphoid cells parallel those of IL-7 (Wil- 
liams,  D. E., manuscript in preparation). Interestingly, IL- 
7K is a subunit of the TSLP receptor (Park,  L. S., manu- 
script in preparation). Thus the phenotypes displayed by IL- 
7K-/-  might be attributed to a functional inactivation of 
both TSLP and IL-7. 
Analyses of previous cytokine and cytokine receptor gene 
knock-out mice have been particularly notable in that none 
have resulted in lymphoid deficiency (28, 32-34). In contrast, 
lymphoid development in IL-7R-/-  mice is severely im- 
paired and reveals a unique, nonredundant role of IL-7R in 
the formation of B and T  cell lineages. 
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